These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 25355935

  • 1. Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata.
    Li H, Chen Z, Zhang C, Gao Y, Zhang X, Sun S.
    J Med Microbiol; 2015 Jan; 64(Pt 1):44-52. PubMed ID: 25355935
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
    Denardi LB, Mario DA, Loreto ÉS, Santurio JM, Alves SH.
    Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
    [Abstract] [Full Text] [Related]

  • 4. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata].
    Shen YZ, Lu HZ, Zhang YX.
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660
    [Abstract] [Full Text] [Related]

  • 5. Expression of ERG11 and efflux pump genes CDR1, CDR2 and SNQ2 in voriconazole susceptible and resistant Candida glabrata strains.
    Navarro-Rodríguez P, Martin-Vicente A, López-Fernández L, Guarro J, Capilla J.
    Med Mycol; 2020 Jan 01; 58(1):30-38. PubMed ID: 30843047
    [Abstract] [Full Text] [Related]

  • 6. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
    Vermitsky JP, Edlind TD.
    Antimicrob Agents Chemother; 2004 Oct 01; 48(10):3773-81. PubMed ID: 15388433
    [Abstract] [Full Text] [Related]

  • 7. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD.
    Mol Microbiol; 2006 Aug 01; 61(3):704-22. PubMed ID: 16803598
    [Abstract] [Full Text] [Related]

  • 8. Fluconazole resistance in Candida glabrata is associated with increased bud formation and metallothionein production.
    Samaranayake YH, Cheung BPK, Wang Y, Yau JYY, Yeung KWS, Samaranayake LP.
    J Med Microbiol; 2013 Feb 01; 62(Pt 2):303-318. PubMed ID: 23002065
    [Abstract] [Full Text] [Related]

  • 9. A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC)--combining tacrolimus with FLC.
    Li H, Zhang C, Chen Z, Shi W, Sun S.
    FEMS Yeast Res; 2014 Aug 01; 14(5):808-11. PubMed ID: 24830342
    [Abstract] [Full Text] [Related]

  • 10. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
    Gohar AA, Badali H, Shokohi T, Nabili M, Amirrajab N, Moazeni M.
    Mycopathologia; 2017 Apr 01; 182(3-4):273-284. PubMed ID: 27744635
    [Abstract] [Full Text] [Related]

  • 11. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG, Pina-Vaz C.
    FEMS Yeast Res; 2009 Jun 01; 9(4):618-25. PubMed ID: 19416368
    [Abstract] [Full Text] [Related]

  • 12. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B.
    J Antimicrob Chemother; 2008 Dec 01; 62(6):1379-85. PubMed ID: 18782778
    [Abstract] [Full Text] [Related]

  • 13. Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
    Whaley SG, Zhang Q, Caudle KE, Rogers PD.
    Antimicrob Agents Chemother; 2018 Oct 01; 62(10):. PubMed ID: 30038038
    [Abstract] [Full Text] [Related]

  • 14. Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.
    Ben-Ami R, Zimmerman O, Finn T, Amit S, Novikov A, Wertheimer N, Lurie-Weinberger M, Berman J.
    mBio; 2016 Aug 02; 7(4):. PubMed ID: 27486188
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.
    Szweda P, Gucwa K, Romanowska E, Dzierz Anowska-Fangrat K, Naumiuk Ł, Brillowska-Da Browska A, Wojciechowska-Koszko I, Milewski S.
    J Med Microbiol; 2015 Jun 02; 64(6):610-619. PubMed ID: 25818698
    [Abstract] [Full Text] [Related]

  • 16. In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.
    Adams EK, Ashcraft DS, Pankey GA.
    Am J Med Sci; 2016 Mar 02; 351(3):265-70. PubMed ID: 26992255
    [Abstract] [Full Text] [Related]

  • 17. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
    Nagayoshi Y, Miyazaki T, Shimamura S, Nakayama H, Minematsu A, Yamauchi S, Takazono T, Nakamura S, Yanagihara K, Kohno S, Mukae H, Izumikawa K.
    PLoS One; 2017 Mar 02; 12(7):e0180990. PubMed ID: 28700656
    [Abstract] [Full Text] [Related]

  • 18. Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata.
    Abbes S, Mary C, Sellami H, Michel-Nguyen A, Ayadi A, Ranque S.
    Front Cell Infect Microbiol; 2013 Mar 02; 3():74. PubMed ID: 24273749
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of four calcium channel blockers as fluconazole resistance inhibitors in Candida glabrata.
    Alnajjar LM, Bulatova NR, Darwish RM.
    J Glob Antimicrob Resist; 2018 Sep 02; 14():185-189. PubMed ID: 29665423
    [Abstract] [Full Text] [Related]

  • 20. The Inhibitory Effect of Human Beta-defensin-3 on Candida Glabrata Isolated from Patients with Candidiasis.
    Inthanachai T, Thammahong A, Edwards SW, Virakul S, Kiatsurayanon C, Chiewchengchol D.
    Immunol Invest; 2021 Jan 02; 50(1):80-91. PubMed ID: 32316784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.